Skip to main content
Top
Published in: Current HIV/AIDS Reports 2/2014

01-06-2014 | The Global Epidemic (S Vermund, Section Editor)

A Lifecycle Approach to HIV Prevention in African Women and Children

Authors: Alison C. Roxby, Jennifer A. Unger, Jennifer A. Slyker, John Kinuthia, Andrew Lewis, Grace John-Stewart, Judd L. Walson

Published in: Current HIV/AIDS Reports | Issue 2/2014

Login to get access

Abstract

Effective biomedical and structural HIV prevention approaches are being implemented throughout sub-Saharan Africa. A “lifecycle approach” to HIV prevention recognizes the interconnectedness of the health of women, children and adolescents, and prioritizes interventions that have benefits across these populations. We review new biomedical prevention strategies for women, adolescents and children, structural prevention approaches, and new modalities for eliminating infant HIV infection, and discuss the implications of a lifecycle approach for the success of these methods. Some examples of the lifecycle approach include evaluating education and HIV prevention strategies among adolescent girls not only for their role in reducing risk of HIV infection and early pregnancy, but also to promote healthy adolescents who will have healthier future children. Similarly, early childhood interventions such as exclusive breastfeeding not only prevent HIV, but also contribute to better child and adolescent health outcomes. The most ambitious biomedical infant HIV prevention effort, Option B+, also represents a lifecycle approach by leveraging the prevention benefits of optimal HIV treatment for mothers; maternal survival benefits from Option B+ may have ultimately more health impact on children than the prevention of infant HIV in isolation. The potential for synergistic and additive benefits of lifecycle interventions should be considered when scaling up HIV prevention efforts in sub-Saharan Africa.
Literature
1.
go back to reference United Nations. United Nations millenium development goals report 2010. New York, NY; 2010. United Nations. United Nations millenium development goals report 2010. New York, NY; 2010.
2.
go back to reference Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493–505.PubMedCentralPubMedCrossRef Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493–505.PubMedCentralPubMedCrossRef
3.
go back to reference Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367:399–410.PubMedCentralPubMedCrossRef Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367:399–410.PubMedCentralPubMedCrossRef
4.
go back to reference Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367:423–34.PubMedCrossRef Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367:423–34.PubMedCrossRef
5.
go back to reference Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329:1168–74.PubMedCentralPubMedCrossRef Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329:1168–74.PubMedCentralPubMedCrossRef
6.
go back to reference Marrazzo JM, Ramjee G, Nair G, Palanee T, Mkhize B, et al. Pre-exposure prophylaxis for HIV in women: daily oral tenofovir, oral tenofovir/emtricitabine, or vaginal tenofovir gel in the VOICE study (MTN-003). 2013 Conference on Retroviruses and Opportunistic Infections. Atlanta, GA; 2013. Marrazzo JM, Ramjee G, Nair G, Palanee T, Mkhize B, et al. Pre-exposure prophylaxis for HIV in women: daily oral tenofovir, oral tenofovir/emtricitabine, or vaginal tenofovir gel in the VOICE study (MTN-003). 2013 Conference on Retroviruses and Opportunistic Infections. Atlanta, GA; 2013.
7.
go back to reference Abdool Karim Q, Kharsany AB, Frohlich JA, Werner L, Mlotshwa M, et al. HIV incidence in young girls in KwaZulu-Natal, South Africa–public health imperative for their inclusion in HIV biomedical intervention trials. AIDS Behav. 2012;16:1870–6.PubMedCrossRef Abdool Karim Q, Kharsany AB, Frohlich JA, Werner L, Mlotshwa M, et al. HIV incidence in young girls in KwaZulu-Natal, South Africa–public health imperative for their inclusion in HIV biomedical intervention trials. AIDS Behav. 2012;16:1870–6.PubMedCrossRef
8.
go back to reference Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012;367:411–22.PubMedCentralPubMedCrossRef Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012;367:411–22.PubMedCentralPubMedCrossRef
9.
go back to reference Friend DR, Kiser PF. Assessment of topical microbicides to prevent HIV-1 transmission: concepts, testing, lessons learned. Antiviral Res. 2013;99:391–400.PubMedCrossRef Friend DR, Kiser PF. Assessment of topical microbicides to prevent HIV-1 transmission: concepts, testing, lessons learned. Antiviral Res. 2013;99:391–400.PubMedCrossRef
10.
go back to reference Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005;2:e298.PubMedCentralPubMedCrossRef Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005;2:e298.PubMedCentralPubMedCrossRef
11.
go back to reference Bailey RC, Moses S, Parker CB, Agot K, Maclean I, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007;369:643–56.PubMedCrossRef Bailey RC, Moses S, Parker CB, Agot K, Maclean I, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007;369:643–56.PubMedCrossRef
12.
go back to reference Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369:657–66.PubMedCrossRef Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369:657–66.PubMedCrossRef
13.•
go back to reference Auvert B, Taljaard D, Rech D, Lissouba P, Singh B, et al. Association of the ANRS-12126 male circumcision project with HIV levels among men in a South African township: evaluation of effectiveness using cross-sectional surveys. PLoS Med. 2013;10:e1001509. Using population surveys in an area where circumcision was recently introduced, this study showed durable reductions in HIV prevalence among circumcised men and 19 % lower HIV prevalence than would have been expected without the voluntary male circumcision program.PubMedCentralPubMedCrossRef Auvert B, Taljaard D, Rech D, Lissouba P, Singh B, et al. Association of the ANRS-12126 male circumcision project with HIV levels among men in a South African township: evaluation of effectiveness using cross-sectional surveys. PLoS Med. 2013;10:e1001509. Using population surveys in an area where circumcision was recently introduced, this study showed durable reductions in HIV prevalence among circumcised men and 19 % lower HIV prevalence than would have been expected without the voluntary male circumcision program.PubMedCentralPubMedCrossRef
14.
go back to reference Centers for Disease Control and Prevention. Progress in voluntary medical male circumcision service provision - Kenya, 2008-2011. MMWR Morb Mortal Wkly Rep. 2012;61:957–61. Centers for Disease Control and Prevention. Progress in voluntary medical male circumcision service provision - Kenya, 2008-2011. MMWR Morb Mortal Wkly Rep. 2012;61:957–61.
15.
16.
go back to reference Baird SJ, Garfein RS, McIntosh CT, Ozler B. Effect of a cash transfer programme for schooling on prevalence of HIV and herpes simplex type 2 in Malawi: a cluster randomised trial. Lancet. 2012;379:1320–9.PubMedCrossRef Baird SJ, Garfein RS, McIntosh CT, Ozler B. Effect of a cash transfer programme for schooling on prevalence of HIV and herpes simplex type 2 in Malawi: a cluster randomised trial. Lancet. 2012;379:1320–9.PubMedCrossRef
17.
go back to reference Pettifor A, MacPhail C, Nguyen N, Rosenberg M. Can money prevent the spread of HIV? A review of cash payments for HIV prevention. AIDS Behav. 2012;16:1729–38.PubMedCentralPubMedCrossRef Pettifor A, MacPhail C, Nguyen N, Rosenberg M. Can money prevent the spread of HIV? A review of cash payments for HIV prevention. AIDS Behav. 2012;16:1729–38.PubMedCentralPubMedCrossRef
18.•
go back to reference Heise L, Lutz B, Ranganathan M, Watts C. Cash transfers for HIV prevention: considering their potential. J Int AIDS Soc. 2013;16:18615. This paper reviews the available evidence on conditional cash transfers and HIV prevention including recommendations for future research.PubMedCentralPubMedCrossRef Heise L, Lutz B, Ranganathan M, Watts C. Cash transfers for HIV prevention: considering their potential. J Int AIDS Soc. 2013;16:18615. This paper reviews the available evidence on conditional cash transfers and HIV prevention including recommendations for future research.PubMedCentralPubMedCrossRef
19.
go back to reference de Walque D, Dow WH, Nathan R, Abdul R, Abilahi F, et al. Incentivising safe sex: a randomised trial of conditional cash transfers for HIV and sexually transmitted infection prevention in rural Tanzania. BMJ Open. 2012;2:e000747.PubMedCentralPubMedCrossRef de Walque D, Dow WH, Nathan R, Abdul R, Abilahi F, et al. Incentivising safe sex: a randomised trial of conditional cash transfers for HIV and sexually transmitted infection prevention in rural Tanzania. BMJ Open. 2012;2:e000747.PubMedCentralPubMedCrossRef
20.
go back to reference Cowan F, Pettifor A. HIV in adolescents in sub-Saharan Africa. Curr Opin HIV AIDS. 2009;4:288–93.PubMedCrossRef Cowan F, Pettifor A. HIV in adolescents in sub-Saharan Africa. Curr Opin HIV AIDS. 2009;4:288–93.PubMedCrossRef
21.
go back to reference Hardee K, Gay J, Croce-Galis M, Peltz A. Strengthening the enabling environment for women and girls: what is the evidence in social and structural approaches in the HIV response? J Int AIDS Soc. 2014;17:18619.PubMedCentralPubMedCrossRef Hardee K, Gay J, Croce-Galis M, Peltz A. Strengthening the enabling environment for women and girls: what is the evidence in social and structural approaches in the HIV response? J Int AIDS Soc. 2014;17:18619.PubMedCentralPubMedCrossRef
22.••
go back to reference World Health Organization. Programmatic update: Use of antiretroviral drugs for treating pregnant woman and preventing HIV infection in infants. 2012. This report outlines the rationale for Options B and B+ for prevention of mother-to-child transmission of HIV and describes the benefits to mothers, infants and partners. World Health Organization. Programmatic update: Use of antiretroviral drugs for treating pregnant woman and preventing HIV infection in infants. 2012. This report outlines the rationale for Options B and B+ for prevention of mother-to-child transmission of HIV and describes the benefits to mothers, infants and partners.
23.
go back to reference Stringer EM, Ekouevi DK, Coetzee D, Tih PM, Creek TL, et al. Coverage of nevirapine-based services to prevent mother-to-child HIV transmission in 4 African countries. JAMA. 2010;304:293–302.PubMedCrossRef Stringer EM, Ekouevi DK, Coetzee D, Tih PM, Creek TL, et al. Coverage of nevirapine-based services to prevent mother-to-child HIV transmission in 4 African countries. JAMA. 2010;304:293–302.PubMedCrossRef
24.•
go back to reference Sibanda EL, Weller IV, Hakim JG, Cowan FM. The magnitude of loss to follow-up of HIV-exposed infants along the prevention of mother-to-child HIV transmission continuum of care: a systematic review and meta-analysis. AIDS. 2013;27:2787–97. This review pools data from multiple published studies worldwide and shows that HIV-exposed children are highly unlikely to receive all services; based on their estimates, only 20 % of infants are followed to a postnatal test.PubMedCentralPubMedCrossRef Sibanda EL, Weller IV, Hakim JG, Cowan FM. The magnitude of loss to follow-up of HIV-exposed infants along the prevention of mother-to-child HIV transmission continuum of care: a systematic review and meta-analysis. AIDS. 2013;27:2787–97. This review pools data from multiple published studies worldwide and shows that HIV-exposed children are highly unlikely to receive all services; based on their estimates, only 20 % of infants are followed to a postnatal test.PubMedCentralPubMedCrossRef
25.
go back to reference Wettstein C, Mugglin C, Egger M, Blaser N, Vizcaya LS, et al. Missed opportunities to prevent mother-to-child-transmission: systematic review and meta-analysis. AIDS. 2012;26:2361–73.PubMedCentralPubMedCrossRef Wettstein C, Mugglin C, Egger M, Blaser N, Vizcaya LS, et al. Missed opportunities to prevent mother-to-child-transmission: systematic review and meta-analysis. AIDS. 2012;26:2361–73.PubMedCentralPubMedCrossRef
26.
go back to reference Homsy J, Moore D, Barasa A, Were W, Likicho C, et al. Breastfeeding, mother-to-child HIV transmission, and mortality among infants born to HIV-Infected women on highly active antiretroviral therapy in rural Uganda. J Acquir Immune Defic Syndr. 2010;53:28–35.PubMedCrossRef Homsy J, Moore D, Barasa A, Were W, Likicho C, et al. Breastfeeding, mother-to-child HIV transmission, and mortality among infants born to HIV-Infected women on highly active antiretroviral therapy in rural Uganda. J Acquir Immune Defic Syndr. 2010;53:28–35.PubMedCrossRef
27.
go back to reference Shapiro RL, Hughes MD, Ogwu A, Kitch D, Lockman S, et al. Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med. 2010;362:2282–94.PubMedCentralPubMedCrossRef Shapiro RL, Hughes MD, Ogwu A, Kitch D, Lockman S, et al. Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med. 2010;362:2282–94.PubMedCentralPubMedCrossRef
28.
go back to reference Mbori-Ngacha D, Nduati R, John G, Reilly M, Richardson B, et al. Morbidity and mortality in breastfed and formula-fed infants of HIV-1-infected women: a randomized clinical trial. JAMA. 2001;286:2413–20.PubMedCentralPubMedCrossRef Mbori-Ngacha D, Nduati R, John G, Reilly M, Richardson B, et al. Morbidity and mortality in breastfed and formula-fed infants of HIV-1-infected women: a randomized clinical trial. JAMA. 2001;286:2413–20.PubMedCentralPubMedCrossRef
29.
go back to reference Thomas TK, Masaba R, Borkowf CB, Ndivo R, Zeh C, et al. Triple-antiretroviral prophylaxis to prevent mother-to-child HIV transmission through breastfeeding–the Kisumu Breastfeeding Study, Kenya: a clinical trial. PLoS Med. 2011;8:e1001015.PubMedCentralPubMedCrossRef Thomas TK, Masaba R, Borkowf CB, Ndivo R, Zeh C, et al. Triple-antiretroviral prophylaxis to prevent mother-to-child HIV transmission through breastfeeding–the Kisumu Breastfeeding Study, Kenya: a clinical trial. PLoS Med. 2011;8:e1001015.PubMedCentralPubMedCrossRef
30.
go back to reference Watts DH, Brown ER, Maldonado Y, Herron C, Chipato T, et al. HIV disease progression in the first year after delivery among African women followed in the HPTN 046 clinical trial. J Acquir Immune Defic Syndr. 2013;64:299–306.PubMedCrossRef Watts DH, Brown ER, Maldonado Y, Herron C, Chipato T, et al. HIV disease progression in the first year after delivery among African women followed in the HPTN 046 clinical trial. J Acquir Immune Defic Syndr. 2013;64:299–306.PubMedCrossRef
31.
go back to reference Centers for Disease Control and Prevention. Impact of an innovative approach to prevent mother-to-child transmission of HIV–Malawi, July 2011-September 2012. MMWR Morb Mortal Wkly Rep. 2013;62:148–51. Centers for Disease Control and Prevention. Impact of an innovative approach to prevent mother-to-child transmission of HIV–Malawi, July 2011-September 2012. MMWR Morb Mortal Wkly Rep. 2013;62:148–51.
32.••
go back to reference Zaba B, Calvert C, Marston M, Isingo R, Nakiyingi-Miiro J, et al. Effect of HIV infection on pregnancy-related mortality in sub-Saharan Africa: secondary analyses of pooled community-based data from the network for Analysing Longitudinal Population-based HIV/AIDS data on Africa (ALPHA). Lancet. 2013;381:1763–71. Using pooled data from East and Southern Africa, this paper concluded that pregnant and postpartum HIV-infected women experience 8 times the mortality of uninfected women, and predicted that 24 % of maternal death in Africa is attributable to HIV.PubMedCrossRef Zaba B, Calvert C, Marston M, Isingo R, Nakiyingi-Miiro J, et al. Effect of HIV infection on pregnancy-related mortality in sub-Saharan Africa: secondary analyses of pooled community-based data from the network for Analysing Longitudinal Population-based HIV/AIDS data on Africa (ALPHA). Lancet. 2013;381:1763–71. Using pooled data from East and Southern Africa, this paper concluded that pregnant and postpartum HIV-infected women experience 8 times the mortality of uninfected women, and predicted that 24 % of maternal death in Africa is attributable to HIV.PubMedCrossRef
33.
go back to reference Moodley J, Pattinson RC, Baxter C, Sibeko S, Abdool Karim Q. Strengthening HIV services for pregnant women: an opportunity to reduce maternal mortality rates in Southern Africa/sub-Saharan Africa. BJOG. 2011;118:219–25.PubMedCrossRef Moodley J, Pattinson RC, Baxter C, Sibeko S, Abdool Karim Q. Strengthening HIV services for pregnant women: an opportunity to reduce maternal mortality rates in Southern Africa/sub-Saharan Africa. BJOG. 2011;118:219–25.PubMedCrossRef
34.
go back to reference World Health Organization. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: recommendations for a public health approach. 2010 Version. Geneva; 2010. World Health Organization. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: recommendations for a public health approach. 2010 Version. Geneva; 2010.
35.
go back to reference UNAIDS. UNAIDS report on the global HIV epidemic; 2013. UNAIDS. UNAIDS report on the global HIV epidemic; 2013.
36.
go back to reference Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008;359:2233–44.PubMedCentralPubMedCrossRef Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008;359:2233–44.PubMedCentralPubMedCrossRef
37.
go back to reference Zunza M, Mercer GD, Thabane L, Esser M, Cotton MF. Effects of postnatal interventions for the reduction of vertical HIV transmission on infant growth and non-HIV infections: a systematic review. J Int AIDS Soc. 2013;16:18865.PubMedCentralPubMedCrossRef Zunza M, Mercer GD, Thabane L, Esser M, Cotton MF. Effects of postnatal interventions for the reduction of vertical HIV transmission on infant growth and non-HIV infections: a systematic review. J Int AIDS Soc. 2013;16:18865.PubMedCentralPubMedCrossRef
38.
go back to reference Braun M, Kabue MM, McCollum ED, Ahmed S, Kim M, et al. Inadequate coordination of maternal and infant HIV services detrimentally affects early infant diagnosis outcomes in Lilongwe, Malawi. J Acquir Immune Defic Syndr. 2011;56:e122–8.PubMedCentralPubMedCrossRef Braun M, Kabue MM, McCollum ED, Ahmed S, Kim M, et al. Inadequate coordination of maternal and infant HIV services detrimentally affects early infant diagnosis outcomes in Lilongwe, Malawi. J Acquir Immune Defic Syndr. 2011;56:e122–8.PubMedCentralPubMedCrossRef
39.
go back to reference Ciampa PJ, Burlison JR, Blevins M, Sidat M, Moon TD, et al. Improving retention in the early infant diagnosis of HIV program in rural Mozambique by better service integration. J Acquir Immune Defic Syndr. 2011;58:115–9.PubMedCrossRef Ciampa PJ, Burlison JR, Blevins M, Sidat M, Moon TD, et al. Improving retention in the early infant diagnosis of HIV program in rural Mozambique by better service integration. J Acquir Immune Defic Syndr. 2011;58:115–9.PubMedCrossRef
40.
go back to reference Adebimpe WO. Challenges facing early infant diagnosis of HIV among infants in resource poor settings. Afr J Reprod Health. 2013;17:122–9.PubMed Adebimpe WO. Challenges facing early infant diagnosis of HIV among infants in resource poor settings. Afr J Reprod Health. 2013;17:122–9.PubMed
41.
go back to reference Chi BH, Bolton-Moore C, Holmes CB. Prevention of mother-to-child HIV transmission within the continuum of maternal, newborn, and child health services. Curr Opin HIV AIDS. 2013;8:498–503.PubMedCrossRef Chi BH, Bolton-Moore C, Holmes CB. Prevention of mother-to-child HIV transmission within the continuum of maternal, newborn, and child health services. Curr Opin HIV AIDS. 2013;8:498–503.PubMedCrossRef
42.
go back to reference Ghadrshenas A, Ben Amor Y, Chang J, Dale H, Sherman G, et al. Improved access to early infant diagnosis is a critical part of a child-centric prevention of mother-to-child transmission agenda. AIDS. 2013;27 Suppl 2:S197–205.PubMedCrossRef Ghadrshenas A, Ben Amor Y, Chang J, Dale H, Sherman G, et al. Improved access to early infant diagnosis is a critical part of a child-centric prevention of mother-to-child transmission agenda. AIDS. 2013;27 Suppl 2:S197–205.PubMedCrossRef
43.
44.
go back to reference Nyberg BJ, Yates DD, Lovich R, Coulibaly-Traore D, Sherr L, et al. Saving lives for a lifetime: supporting orphans and vulnerable children impacted by HIV/AIDS. J Acquir Immune Defic Syndr. 2012;60 Suppl 3:S127–35.PubMedCrossRef Nyberg BJ, Yates DD, Lovich R, Coulibaly-Traore D, Sherr L, et al. Saving lives for a lifetime: supporting orphans and vulnerable children impacted by HIV/AIDS. J Acquir Immune Defic Syndr. 2012;60 Suppl 3:S127–35.PubMedCrossRef
45.
go back to reference Amoako Johnson F, Padmadas SS, Smith PW. Orphanhood and vulnerability: a conduit to poor child health outcomes in Rwanda. AIDS Care. 2010;22:314–23.PubMedCrossRef Amoako Johnson F, Padmadas SS, Smith PW. Orphanhood and vulnerability: a conduit to poor child health outcomes in Rwanda. AIDS Care. 2010;22:314–23.PubMedCrossRef
46.
go back to reference Kinuthia J, Kiarie JN, Farquhar C, Richardson B, Nduati R, et al. Cofactors for HIV-1 incidence during pregnancy and postpartum period. Curr HIV Res. 2010;8:510–4.PubMedCentralPubMedCrossRef Kinuthia J, Kiarie JN, Farquhar C, Richardson B, Nduati R, et al. Cofactors for HIV-1 incidence during pregnancy and postpartum period. Curr HIV Res. 2010;8:510–4.PubMedCentralPubMedCrossRef
47.
go back to reference Moodley D, Esterhuizen T, Reddy L, Moodley P, Singh B, et al. Incident HIV infection in pregnant and lactating women and its effect on mother-to-child transmission in South Africa. J Infect Dis. 2011;203:1231–4.PubMedCrossRef Moodley D, Esterhuizen T, Reddy L, Moodley P, Singh B, et al. Incident HIV infection in pregnant and lactating women and its effect on mother-to-child transmission in South Africa. J Infect Dis. 2011;203:1231–4.PubMedCrossRef
48.
go back to reference Theron GB, Shapiro DE, Van Dyke R, Cababasay MP, Louw J, et al. Rapid intrapartum or postpartum HIV testing at a midwife obstetric unit and a district hospital in South Africa. Int J Gynaecol Obstet. 2011;113:44–9.PubMedCentralPubMedCrossRef Theron GB, Shapiro DE, Van Dyke R, Cababasay MP, Louw J, et al. Rapid intrapartum or postpartum HIV testing at a midwife obstetric unit and a district hospital in South Africa. Int J Gynaecol Obstet. 2011;113:44–9.PubMedCentralPubMedCrossRef
49.
go back to reference Humphrey JH, Marinda E, Mutasa K, Moulton LH, Iliff PJ, et al. Mother to child transmission of HIV among Zimbabwean women who seroconverted postnatally: prospective cohort study. BMJ. 2010;341:c6580.PubMedCentralPubMedCrossRef Humphrey JH, Marinda E, Mutasa K, Moulton LH, Iliff PJ, et al. Mother to child transmission of HIV among Zimbabwean women who seroconverted postnatally: prospective cohort study. BMJ. 2010;341:c6580.PubMedCentralPubMedCrossRef
50.
go back to reference Alkema L, Kantorova V, Menozzi C, Biddlecom A. National, regional, and global rates and trends in contraceptive prevalence and unmet need for family planning between 1990 and 2015: a systematic and comprehensive analysis. Lancet. 2013;381:1642–52.PubMedCrossRef Alkema L, Kantorova V, Menozzi C, Biddlecom A. National, regional, and global rates and trends in contraceptive prevalence and unmet need for family planning between 1990 and 2015: a systematic and comprehensive analysis. Lancet. 2013;381:1642–52.PubMedCrossRef
51.•
go back to reference Darroch JE, Singh S. Trends in contraceptive need and use in developing countries in 2003, 2008, and 2012: an analysis of national surveys. Lancet. 2013;381:1756–62. This review analyzes national data on contraceptive use in 2003, 2008 and 2012 including both married and unmarried women, and concludes ongoing high unmet need for contraception, especially in sub-Saharan Africa.PubMedCrossRef Darroch JE, Singh S. Trends in contraceptive need and use in developing countries in 2003, 2008, and 2012: an analysis of national surveys. Lancet. 2013;381:1756–62. This review analyzes national data on contraceptive use in 2003, 2008 and 2012 including both married and unmarried women, and concludes ongoing high unmet need for contraception, especially in sub-Saharan Africa.PubMedCrossRef
52.
go back to reference Heffron R, Donnell D, Rees H, Celum C, Mugo N, et al. (2011) Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis. Heffron R, Donnell D, Rees H, Celum C, Mugo N, et al. (2011) Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis.
53.
go back to reference Polis CB, Phillips SJ, Curtis KM. Hormonal contraceptive use and female-to-male HIV transmission: a systematic review of the epidemiologic evidence. AIDS. 2013;27:493–505.PubMedCrossRef Polis CB, Phillips SJ, Curtis KM. Hormonal contraceptive use and female-to-male HIV transmission: a systematic review of the epidemiologic evidence. AIDS. 2013;27:493–505.PubMedCrossRef
54.
go back to reference Polis CB, Curtis KM. Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence. Lancet Infect Dis. 2013;13:797–808.PubMedCrossRef Polis CB, Curtis KM. Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence. Lancet Infect Dis. 2013;13:797–808.PubMedCrossRef
55.
go back to reference Stuart GS. Fourteen million women with limited options: HIV/AIDS and highly effective reversible contraception in sub-Saharan Africa. Contraception. 2009;80:412–6.PubMedCrossRef Stuart GS. Fourteen million women with limited options: HIV/AIDS and highly effective reversible contraception in sub-Saharan Africa. Contraception. 2009;80:412–6.PubMedCrossRef
56.
go back to reference Peltzer K, Chao LW, Dana P. Family planning among HIV positive and negative prevention of mother to child transmission (PMTCT) clients in a resource poor setting in South Africa. AIDS Behav. 2009;13:973–9.PubMedCrossRef Peltzer K, Chao LW, Dana P. Family planning among HIV positive and negative prevention of mother to child transmission (PMTCT) clients in a resource poor setting in South Africa. AIDS Behav. 2009;13:973–9.PubMedCrossRef
57.
go back to reference Jhangri GS, Heys J, Alibhai A, Rubaale T, Kipp W. Unmet need for effective family planning in HIV-infected individuals: results from a survey in rural Uganda. J Fam Plann Reprod Health Care. 2012;38:23–9.PubMedCrossRef Jhangri GS, Heys J, Alibhai A, Rubaale T, Kipp W. Unmet need for effective family planning in HIV-infected individuals: results from a survey in rural Uganda. J Fam Plann Reprod Health Care. 2012;38:23–9.PubMedCrossRef
58.
go back to reference Leslie JA, Munyambanza E, Adamchak SE, Janowitz B, Grey TW, et al. Without strong integration of family planning into PMTCT services in Rwanda, clients remain with a high unmet need for effective family planning. Afr J Reprod Health. 2010;14:144–6.PubMed Leslie JA, Munyambanza E, Adamchak SE, Janowitz B, Grey TW, et al. Without strong integration of family planning into PMTCT services in Rwanda, clients remain with a high unmet need for effective family planning. Afr J Reprod Health. 2010;14:144–6.PubMed
59.
go back to reference Harrington EK, Newmann SJ, Onono M, Schwartz KD, Bukusi EA, et al. Fertility intentions and interest in integrated family planning services among women living with HIV in Nyanza Province, Kenya: a qualitative study. Infect Dis Obstet Gynecol. 2012;2012:809682.PubMedCentralPubMedCrossRef Harrington EK, Newmann SJ, Onono M, Schwartz KD, Bukusi EA, et al. Fertility intentions and interest in integrated family planning services among women living with HIV in Nyanza Province, Kenya: a qualitative study. Infect Dis Obstet Gynecol. 2012;2012:809682.PubMedCentralPubMedCrossRef
60.
go back to reference Schwartz SR, Rees H, Mehta S, Venter WD, Taha TE, et al. High incidence of unplanned pregnancy after antiretroviral therapy initiation: findings from a prospective cohort study in South Africa. PLoS One. 2012;7:e36039.PubMedCentralPubMedCrossRef Schwartz SR, Rees H, Mehta S, Venter WD, Taha TE, et al. High incidence of unplanned pregnancy after antiretroviral therapy initiation: findings from a prospective cohort study in South Africa. PLoS One. 2012;7:e36039.PubMedCentralPubMedCrossRef
61.
go back to reference Wilcher R, Hoke T, Adamchak SE, Cates Jr W. Integration of family planning into HIV services: a synthesis of recent evidence. AIDS. 2013;27 Suppl 1:S65–75.PubMedCrossRef Wilcher R, Hoke T, Adamchak SE, Cates Jr W. Integration of family planning into HIV services: a synthesis of recent evidence. AIDS. 2013;27 Suppl 1:S65–75.PubMedCrossRef
62.
go back to reference Wilcher R, Petruney T, Cates W. The role of family planning in elimination of new pediatric HIV infection. Curr Opin HIV AIDS. 2013;8:490–7.PubMedCrossRef Wilcher R, Petruney T, Cates W. The role of family planning in elimination of new pediatric HIV infection. Curr Opin HIV AIDS. 2013;8:490–7.PubMedCrossRef
63.
go back to reference Chang LW, Serwadda D, Quinn TC, Wawer MJ, Gray RH, et al. Combination implementation for HIV prevention: moving from clinical trial evidence to population-level effects. Lancet Infect Dis. 2013;13:65–76.PubMedCentralPubMedCrossRef Chang LW, Serwadda D, Quinn TC, Wawer MJ, Gray RH, et al. Combination implementation for HIV prevention: moving from clinical trial evidence to population-level effects. Lancet Infect Dis. 2013;13:65–76.PubMedCentralPubMedCrossRef
65.
go back to reference Alsallaq RA, Baeten JM, Celum CL, Hughes JP, Abu-Raddad LJ, et al. Understanding the potential impact of a combination HIV prevention intervention in a hyper-endemic community. PLoS One. 2013;8:e54575.PubMedCentralPubMedCrossRef Alsallaq RA, Baeten JM, Celum CL, Hughes JP, Abu-Raddad LJ, et al. Understanding the potential impact of a combination HIV prevention intervention in a hyper-endemic community. PLoS One. 2013;8:e54575.PubMedCentralPubMedCrossRef
66.
go back to reference Gounder CR, Chaisson RE. A diagonal approach to building primary healthcare systems in resource-limited settings: women-centred integration of HIV/AIDS, tuberculosis, malaria, MCH and NCD initiatives. Trop Med Int Health. 2012;17:1426–31.PubMedCrossRef Gounder CR, Chaisson RE. A diagonal approach to building primary healthcare systems in resource-limited settings: women-centred integration of HIV/AIDS, tuberculosis, malaria, MCH and NCD initiatives. Trop Med Int Health. 2012;17:1426–31.PubMedCrossRef
Metadata
Title
A Lifecycle Approach to HIV Prevention in African Women and Children
Authors
Alison C. Roxby
Jennifer A. Unger
Jennifer A. Slyker
John Kinuthia
Andrew Lewis
Grace John-Stewart
Judd L. Walson
Publication date
01-06-2014
Publisher
Springer US
Published in
Current HIV/AIDS Reports / Issue 2/2014
Print ISSN: 1548-3568
Electronic ISSN: 1548-3576
DOI
https://doi.org/10.1007/s11904-014-0203-2

Other articles of this Issue 2/2014

Current HIV/AIDS Reports 2/2014 Go to the issue

The Global Epidemic (S Vermund, Section Editor)

Update on HIV in Western Europe

The Global Epidemic (S Vermund, Section Editor)

Understanding HIV Compartments and Reservoirs

The Global Epidemic (S Vermund, Section Editor)

The Changing face of HIV in Latin America and the Caribbean

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine